Ubs Group Ag I Teos Therapeutics, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 43,765 shares of ITOS stock, worth $317,733. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,765

Previous 29,386 48.93%

Holding current value

$317,733

Previous $436,000 2.29%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.09 - $17.97 $145,084 - $258,390	14,379 Added 48.93%	43,765 $446,000
Q2 2024 Aug 13, 2024	SELL	$10.33 - $18.09 $306,883 - $537,417	-29,708 Reduced 50.27%	29,386 $436,000
Q1 2024 May 13, 2024	BUY	$9.89 - $13.64 $136,580 - $188,368	13,810 Added 30.5%	59,094 $806,000
Q4 2023 Feb 09, 2024	BUY	$8.57 - $11.06 $189,894 - $245,067	22,158 Added 95.81%	45,284 $495,000
Q3 2023 Nov 09, 2023	SELL	$10.95 - $14.6 $236,399 - $315,199	-21,589 Reduced 48.28%	23,126 $253,000
Q2 2023 Aug 11, 2023	BUY	$12.93 - $18.05 $13,809 - $19,277	1,068 Added 2.45%	44,715 $592,000
Q1 2023 May 12, 2023	SELL	$13.02 - $22.62 $614,778 - $1.07 Million	-47,218 Reduced 51.97%	43,647 $594,000
Q4 2022 Feb 08, 2023	BUY	$17.77 - $21.6 $409,189 - $497,383	23,027 Added 33.94%	90,865 $1.77 Million
Q3 2022 Nov 10, 2022	SELL	$18.6 - $27.25 $1.68 Million - $2.46 Million	-90,366 Reduced 57.12%	67,838 $1.29 Million
Q2 2022 Aug 10, 2022	SELL	$16.57 - $35.1 $206,893 - $438,258	-12,486 Reduced 7.32%	158,204 $3.26 Million
Q1 2022 May 16, 2022	BUY	$31.92 - $47.45 $4.24 Million - $6.31 Million	132,934 Added 352.09%	170,690 $5.49 Million
Q4 2021 Feb 14, 2022	BUY	$26.23 - $47.86 $986,798 - $1.8 Million	37,621 Added 27867.41%	37,756 $1.76 Million
Q3 2021 Nov 15, 2021	SELL	$23.91 - $29.58 $65,728 - $81,315	-2,749 Reduced 95.32%	135 $4,000
Q2 2021 Aug 13, 2021	SELL	$17.9 - $36.1 $172,573 - $348,040	-9,641 Reduced 76.97%	2,884 $74,000
Q1 2021 May 12, 2021	BUY	$30.86 - $44.2 $275,240 - $394,219	8,919 Added 247.34%	12,525 $428,000
Q4 2020 Feb 11, 2021	BUY	$21.59 - $33.95 $77,853 - $122,423	3,606 New	3,606 $122,000

Others Institutions Holding ITOS

# of Institutions

166

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $258M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account